Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Supramolecular systems

October 14, 2022 Drug delivery / Pharma applications / Supramolecular systems

Stimuli-responsive cyclodextrin-based supramolecular assemblies as drug carriers

In this review with 169 references, the recent advances in stimuli-responsive supramolecular assemblies based on the host–guest chemistry of CDs

Continue reading

October 7, 2022 CD as API / Pharma applications / Supramolecular systems

Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis

A promising therapy for atherosclerosis treatment was designed by targeting LXR receptor (LXR) on atherosclerotic macrophage, where LXR activation could

Continue reading

September 27, 2022 CD derivatives / Drug delivery / Pharma applications / Supramolecular systems

Advances in the development of cyclodextrin-based nanogels/microgels for biomedical applications: Drug delivery and beyond

Nanogels/microgels are swollen cross-linked polymer networks with tunable physicochemical properties and are commonly employed for the effective delivery of hydrophilic

Continue reading

September 21, 2022 Pharma applications / Supramolecular systems

Lipid-based artificial motors – liposome movements via cholesterol extraction

In this work, it is demonstrated that liposome active motion takes advantage of mainly a pair of intrinsic material properties

Continue reading

September 20, 2022 CD derivatives / Drug delivery / Life sciences / Supramolecular systems

New US patent application on ternary CD/small guest molecule/protein interactions

Cyclolab Ltd filed a patent application (US20220282001) on cyclodextrin containing physical mixtures and inclusion complexes that show improved protein stabilizing

Continue reading

July 22, 2022 Pharma applications / Supramolecular systems

Antidote-like Effect of Cyclodextrins on Plant Neurotoxin Veratridine

Veratridine (VTD) is a plant neurotoxin that acts by blocking the voltage-gated sodium channels (VGSC) of cell membranes. Symptoms of

Continue reading

June 27, 2022 CD derivatives / Gene delivery / Supramolecular systems

Matthieu SOLLOGOUB at ICS 20

Matthieu Sollogoub, professor of Biological and Supramolecular Glycochemistry at Sorbonne University gave a plenary lecture at the 20th International Cyclodextrin

Continue reading

March 24, 2022 CD as API / CD derivatives / Pharma applications / Supramolecular systems

Antidote-like effect of SBECD of plant neurotoxin veratridine on neuro-2a cell viability

A research team consisting of scientists located in Spain and Denmark have successfully proven that the formation of inclusion complexes

Continue reading

March 12, 2022 Pharma applications / Supramolecular systems

Thiolated amphiphilic beta-cyclodextrin-decorated gold colloids: Synthesis, supramolecular nanoassemblies and controlled release of dopamine

We report a hybrid nanoassembly based on gold colloids decorated with a new thiolated amphiphilic cyclodextrin complexing dopamine (AuNPs@SC16SH/DA). The

Continue reading

March 4, 2022 Pharma applications / Supramolecular systems

β-Cyclodextrin-Derivative-Functionalized Graphene Oxide/Graphitic Carbon Nitride Composites with a Synergistic Effect for Rapid and Efficient Sterilization

The nonselectivity of phototherapy and the hydrophobicity of phototherapy agents limit their application in the treatment of antibiotic-resistant bacteria. In

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 Next Posts»

Recent Posts

  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief
  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (833)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,242)
  • Supramolecular systems (45)
  • Uncategorized (176)

Top Posts

  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Cyclodextrins in 3D and 4D printing
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • A new multi-compendia modified beta-cyclodextrin, Kleptose® HPB-LB parenteral grade
  • Future automobiles made from supramolecular polymers are reality?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,471 other subscribers
Loading Comments...